Risk assessment with gut microbiome and metabolite markers in NAFLD development

A Unified Approach to Interpreting Model Predictions

Lundberg, S., & Lee, S.-I. (2017) · arXiv · doi:10.48550/arxiv.1705.07874 · Cited by 23,707 · see citing works

pROC: an open-source package for R and S+ to analyze and compare ROC curves

Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697 · see citing works

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · see citing works

Building Predictive Models in R Using the caret Package

Kühn, M. (2008) · Journal of Statistical Software · doi:10.18637/jss.v028.i05 · Cited by 9,986 · see citing works

Aligning sequence reads, clone sequences and assembly contigs with BWA-MEMPreprint

Li, H. (2013) · arXiv (Cornell University) · doi:10.48550/arxiv.1303.3997 · Cited by 9,540 · see citing works

Human gut microbes associated with obesity

Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · see citing works

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · see citing works

VEGAN, a package of R functions for community ecology

Dixon, P. M. (2003) · Journal of Vegetation Science · doi:10.1111/j.1654-1103.2003.tb02228.x · Cited by 6,783 · see citing works

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · see citing works

The gut microbiota as an environmental factor that regulates fat storage

Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · see citing works

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697 · see citing works

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021 · see citing works

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836 · see citing works

Richness of human gut microbiome correlates with metabolic markers

Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662 · see citing works

ranger : A Fast Implementation of Random Forests for High Dimensional Data in C++ and R

Wright, M. N., & Ziegler, A. (2017) · Journal of Statistical Software · doi:10.18637/jss.v077.i01 · Cited by 3,814 · see citing works

MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease

Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286 · see citing works

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works

Personalized nutrition by prediction of glycemic responses

Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929 · see citing works

Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism

Wahlstrom, A. M., Sayin, S. I., Marschall, H., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,903 · see citing works

Differential abundance analysis for microbial marker-gene surveys

Paulson, J. N., Stine, O. C., Bravo, H. C., & Pop, M. (2013) · Nature Methods · doi:10.1038/nmeth.2658 · Cited by 2,437 · see citing works

MetaPhlAn2 for enhanced metagenomic taxonomic profiling

Truong, D. T., Franzosa, E. A., Tickle, T. L., Scholz, M., Weingart, G., Pasolli, E., Tett, A., Huttenhower, C., & Segata, N. (2015) · Nature Methods · doi:10.1038/nmeth.3589 · Cited by 2,185 · see citing works

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166 · see citing works

Diet, Nutrition, and the Prevention of Chronic Diseases

Zimmermann, M. B. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.4.644a · Cited by 2,137 · see citing works

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

Estes, C., Anstee, Q. M., Arias, M., Bantel, H., Bellentani, S., Caballería, J., Colombo, M., Craxı̀, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,986 · see citing works

Variations in the Prevalence of Obesity Among European Countries, and a Consideration of Possible Causes

Blundell, J. E., Baker, J. L., Boyland, E. J., Blaak, E. E., Charzewska, J., Henauw, S. D., Frühbeck, G., González‐Gross, M., Hebebrand, J., Holm, L., et al. (2017) · Obesity Facts · doi:10.1159/000455952 · Cited by 1,980 · see citing works

Explainable machine-learning predictions for the prevention of hypoxaemia during surgery

Lundberg, S. M., Nair, B., Vavilala, M. S., Horibe, M., Eisses, M. J., Adams, T., Liston, D. E., Low, D. K.-W., Newman, S.-F., Kim, J., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0304-0 · Cited by 1,967 · see citing works

Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858 · see citing works

Diet-induced extinctions in the gut microbiota compound over generations

Sonnenburg, E. D., Smits, S. A., Tikhonov, M., Higginbottom, S. K., Wingreen, N. S., & Sonnenburg, J. L. (2016) · Nature · doi:10.1038/nature16504 · Cited by 1,730 · see citing works

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · see citing works

Species-level functional profiling of metagenomes and metatranscriptomes

Franzosa, E. A., McIver, L. J., Rahnavard, G., Thompson, L. R., Schirmer, M., Weingart, G., Lipson, K. S., Knight, R., Caporaso, J. G., Segata, N., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0176-y · Cited by 1,693 · see citing works

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage

Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643 · see citing works

Diet, Nutrition, and the Prevention of Chronic Diseases

Leong, A. (1992) · Pathology · doi:10.1016/s0031-3025(16)36541-2 · Cited by 1,633 · see citing works

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582 · see citing works

Gut microbial metabolites in obesity, NAFLD and T2DM

Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0156-z · Cited by 1,493 · see citing works

A unified catalog of 204,938 reference genomes from the human gut microbiome

Almeida, A., Nayfach, S., Boland, M., Strozzi, F., Beracochea, M., Shi, Z. J., Pollard, K. S., Sakharova, E., Parks, D. H., Hugenholtz, P., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-0603-3 · Cited by 1,367 · see citing works

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,210 · see citing works

Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes

MetaHIT Consortium, Nielsen, H. B., Almeida, M., Juncker, A. S., Rasmussen, S., Li, J., Sunagawa, S., Plichta, D. R., Gautier, L., Pedersen, A. G., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2939 · Cited by 1,184 · see citing works

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123 · see citing works

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

Aron‐Wisnewsky, J., Vigliotti, C., Witjes, J. J., Le, P. T., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,085 · see citing works

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

Cani, P. D., Osto, M., Geurts, L., & Everard, A. (2012) · Gut Microbes · doi:10.4161/gmic.19625 · Cited by 864 · see citing works

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies

Stefan, N., Häring, H., & Cusi, K. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 848 · see citing works

The Economic Costs of Type 2 Diabetes: A Global Systematic Review

Seuring, T., Archangelidi, O., & Suhrcke, M. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0268-9 · Cited by 840 · see citing works

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L., Lundbom, N. M. I., Rissanen, A., Ridderstråle, M., Groop, L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.005 · Cited by 803 · see citing works

Intestinal microbiota in patients with nonalcoholic fatty liver disease

Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749 · see citing works

Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., Heymes, C., Luque, J. L., Anthony, E., Barton, R. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0061-3 · Cited by 720 · see citing works

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

Simon, T. G., Roelstraete, B., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Gut · doi:10.1136/gutjnl-2020-322786 · Cited by 673 · see citing works

Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.035 · Cited by 639 · see citing works

Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice

Li, J., Sung, C. Y. J., Lee, N. P. Y., Ni, Y., Pihlajamäki, J., Panagiotou, G., & El-Nezami, H. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518189113 · Cited by 624 · see citing works

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

Wong, V. W., Adams, L. A., de Lédinghen, V., Wong, G. L., & Sookoian, S. C. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0014-9 · Cited by 617 · see citing works

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

Vilar‐Gómez, E., & Chalasani, N. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.013 · Cited by 608 · see citing works

Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease

Mardinoğlu, A., Ågren, R., Kampf, C., Asplund, A., Uhlén, M., & Nielsen, J. (2014) · Nature Communications · doi:10.1038/ncomms4083 · Cited by 520 · see citing works

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance

Gaggini, M., Carli, F., Rosso, C., Buzzigoli, E., Marietti, M., Latta, V. D., Ciociaro, D., Abate, M. L., Gambino, R., Cassader, M., et al. (2017) · Hepatology · doi:10.1002/hep.29465 · Cited by 467 · see citing works

An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans

Mardinoğlu, A., Wu, H., Björnson, E., Zhang, C., Hakkarainen, A., Räsänen, S., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.005 · Cited by 455 · see citing works

fossil: Palaeoecological and palaeogeographical analysis tools

Vavrek, M. J. (2011) · Cited by 449 · see citing works

Major microbiota dysbiosis in severe obesity: fate after bariatric surgery

Aron-Wisnewsky, J., Prifti, E., Belda, E., Ichou, F., Kayser, B. D., Dao, M. C., Verger, E. O., Hedjazi, L., Bouillot, J.-L., Chevallier, J.-M., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316103 · Cited by 418 · see citing works

Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention

Liu, Y., Wang, Y., Ni, Y., Cheung, C. K. Y., Lam, K. S. L., Wang, Y., Xia, Z., Ye, D., Guo, J., Tse, M. A., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.001 · Cited by 405 · see citing works

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

Li, H., Fang, Q., Gao, F., Fan, J., Zhou, J., Wang, X., Zhang, H., Pan, X., Bao, Y., Xiang, K., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.018 · Cited by 400 · see citing works

Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease

Wang, B., Jiang, X., Cao, M., Ge, J., Bao, Q., Tang, L., Chen, Y., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep32002 · Cited by 380 · see citing works

A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis

Oh, T. G., Kim, S. M., Caussy, C., Fu, T., Guo, J. P., Bassirian, S., Singh, S., Madamba, E. V., Bettencourt, R., Richards, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.005 · Cited by 337 · see citing works

Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines

Chitturi, S., Farrell, G. C., Hashimoto, E., Saibara, T., Lau, G. K. K., Sollano, J. D., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05001.x · Cited by 311 · see citing works

The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice

Kindt, A., Liebisch, G., Clavel, T., Haller, D., Hörmannsperger, G., Yoon, H., Kolmeder, D., Sigruener, A., Krautbauer, S., Seeliger, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05767-4 · Cited by 311 · see citing works

Specific gut microbiota features and metabolic markers in postmenopausal women with obesity

Brahe, L. K., Chatelier, E. L., Prifti, E., Pons, N., Kennedy, S., Hansen, T. F., Pedersen, O. B., Astrup, A. V., Ehrlich, S. D., & Larsen, L. H. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2015.9 · Cited by 305 · see citing works

Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease

Schwimmer, J. B., Johnson, J. S., Angeles, J. E., Behling, C., Belt, P. H., Borecki, I., Bross, C., Durelle, J., Goyal, N. P., Hamilton, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.028 · Cited by 298 · see citing works

Prediction of gestational diabetes based on nationwide electronic health records

Artzi, N. S., Shilo, S., Hadar, E., Rossman, H., Barbash‐Hazan, S., Ben‐Haroush, A., Balicer, R. D., Feldman, B., Wiznitzer, A., & Segal, E. (2020) · Nature Medicine · doi:10.1038/s41591-019-0724-8 · Cited by 289 · see citing works

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Spengler, E. K., & Loomba, R. S. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.06.013 · Cited by 285 · see citing works

Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance

Da Silva, H. E., Teterina, A., Comelli, E. M., Taibi, A., Arendt, B. M., Fischer, S. E., Lou, W., & Allard, J. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-19753-9 · Cited by 283 · see citing works

Microbiome and metabolome features of the cardiometabolic disease spectrum

Fromentin, S., Forslund, S. K., Chechi, K., Aron‐Wisnewsky, J., Chakaroun, R., Nielsen, T., Tremaroli, V., Ji, B., Prifti, E., Myridakis, A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01688-4 · Cited by 277 · see citing works

Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial

Zhang, H.-J., He, J., Pan, L.-L., Ma, Z.-M., Han, C.-K., Chen, C.-S., Chen, Z., Han, H.-W., Chen, S., Sun, Q., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.3202 · Cited by 276 · see citing works

Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?

Aron‐Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M., & Clément, K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.049 · Cited by 245 · see citing works

Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease

Talmor‐Barkan, Y., Bar, N., Shaul, A. A., Shahaf, N., Godneva, A., Bussi, Y., Lotan‐Pompan, M., Weinberger, A., Shechter, A., Chezar‐Azerrad, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01686-6 · Cited by 218 · see citing works

Nonalcoholic fatty liver disease: Evolving paradigms

Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 197 · see citing works

Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophils

Nv, B., Bairamov, I. T., Olenin, A. Y., Shubina, V. S., Teplova, V. V., & Fedotcheva, N. I. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-89 · Cited by 183 · see citing works

Predictable modulation of cancer treatment outcomes by the gut microbiota

(2020) · doi:10.1186/s40168-020-00811-2 · Cited by 175 · see citing works

High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization

Zhao, L., Ni, Y., Su, M., Li, H., Dong, F., Chen, W., Wei, R., Zhang, L., Guiraud, S. P., Martin, F., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00660 · Cited by 145 · see citing works

Microbiota and cancer immunotherapy: in search of microbial signals

Gharaibeh, R. Z., & Jobin, C. (2019) · Gut · doi:10.1136/gutjnl-2018-317220 · Cited by 144 · see citing works

Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study

Jung, H. S., Chang, Y., Kwon, M., Sung, E., Yun, K. E., Cho, Y. K., Shin, H. C., & Ryu, S. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0283-5 · Cited by 144 · see citing works

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

Schattenberg, J. M., Lazarus, J. V., Newsome, P. N., Serfaty, L., Aghemo, A., Augustín, S., Tsochatzis, E. A., de Lédinghen, V., Bugianesi, E., Romero‐Gómez, M., et al. (2021) · Liver International · doi:10.1111/liv.14825 · Cited by 144 · see citing works

Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome

Mayneris‐Perxachs, J., Cardellini, M., Hoyles, L., Latorre, J., Davato, F., Moreno‐Navarrete, J. M., Arnoriaga‐Rodríguez, M., Sérino, M., Abbott, J., Barton, R. H., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01052-7 · Cited by 141 · see citing works

Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study

Alferink, L. J. M., Jong, J. C. K., Erler, N. S., Veldt, B. J., Schoufour, J. D., de Knegt, R. J., Ikram, M. A., Metselaar, H. J., Janssen, H. L. A., Franco, O. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315940 · Cited by 130 · see citing works

Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults

Ruuskanen, M. O., Erawijantari, P. P., Havulinna, A. S., Liu, Y., Méric, G., Tuomilehto, J. O., Inouye, M., Jousilahti, P., Salomaa, V. V., Jain, M., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2358 · Cited by 128 · see citing works

Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes

Menni, C., Zhu, J., Roy, C. I. L., Mompeó, O., Young, K. L., Rebholz, C. M., Selvin, E., North, K. E., Mohney, R. P., Bell, J. T., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1778261 · Cited by 123 · see citing works

High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China

Li, H., Dong, K., Fang, Q., Hou, X., Zhou, M., Bao, Y., Xiang, K., Xu, A., & Jia, W. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.029 · Cited by 118 · see citing works

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development

Sztolsztener, K., Chabowski, A., Harasim‐Symbor, E., Bielawiec, P., & Konstantynowicz-Nowicka, K. (2020) · Biomolecules · doi:10.3390/biom10081133 · Cited by 117 · see citing works

Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions

Loomba, R. S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.028 · Cited by 112 · see citing works

Gut Microbial Carbohydrate Metabolism Hinders Weight Loss in Overweight Adults Undergoing Lifestyle Intervention With a Volumetric Diet

Pedrogo, D. A. M., Jensen, M. D., Dyke, C. T. V., Murray, J. A., Woods, J. A., Chen, J., Kashyap, P., & Nehra, V. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.02.019 · Cited by 97 · see citing works

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus

Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Thacker, L. R., Daita, K., Kang, D. J., White, M. B., Unser, A. B., Fagan, A., Gavis, E. A., et al. (2015) · Scientific Reports · doi:10.1038/srep18559 · Cited by 91 · see citing works

Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease

Rodríguez‐Gallego, E., Guirro, M., Riera-Borrull, M., Hernández‐Aguilera, A., Mariné-Casadó, R., Fernández‐Arroyo, S., Beltrán‐Debón, R., Sabench, F., Hernández, M., Castillo, D. D., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.53 · Cited by 84 · see citing works

A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease

Zheng, R., Du, Z., Wang, M., Mao, Y., & Mao, W. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0913-3 · Cited by 82 · see citing works

Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes?

Chen, P., Hou, X., Hu, G., Wei, L., Jiao, L., Wang, H., Chen, S., Wu, J., Bao, Y., & Jia, W. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0734-8 · Cited by 80 · see citing works

Geranylgeranyl diphosphate synthase (GGPPS) regulates non‐alcoholic fatty liver disease (NAFLD)–fibrosis progression by determining hepatic glucose/fatty acid preference under high‐fat diet conditions

Liu, J., Jiang, S., Zhao, Y., Sun, Q., Zhang, J., Shen, D., Wu, J., Shen, N., Fu, X., Sun, X., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5131 · Cited by 72 · see citing works

A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis

Oh, T. G., Kim, S. M., Caussy, C., Fu, T., Guo, J. P., Bassirian, S., Singh, S., Madamba, E. V., Bettencourt, R., Richards, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.015 · Cited by 68 · see citing works

Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran

Motamed, N., Faraji, A. H., Khonsari, M. R., Maadi, M., Tameshkel, F. S., Keyvani, H., Ajdarkosh, H., Niya, M. H. K., Rezaie, N., & Zamani, F. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.024 · Cited by 65 · see citing works

Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population

Jung, J. Y., Shim, J., Park, S. K., Ryoo, J., Choi, J., Oh, I., Jung, K., Cho, H., Ki, M., Won, Y., et al. (2018) · Hepatology International · doi:10.1007/s12072-018-9892-8 · Cited by 64 · see citing works

Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study

Hodson, L., Bhatia, L. S., Scorletti, E., Smith, D. E., Jackson, N. C., Shojaee‐Moradie, F., Umpleby, A. M., Calder, P. C., & Byrne, C. D. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.9 · Cited by 63 · see citing works

Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study

Cleveland, E. R., Ning, H., Vos, M. B., Lewis, C. E., Rinella, M. E., Carr, J. J., Lloyd‐Jones, D. M., & VanWagner, L. B. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05340-9 · Cited by 59 · see citing works

Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study

Hashemian, M., Merat, S., Poustchi, H., Jafari, E., Radmard, A.-R., Kamangar, F., Freedman, N. D., Hekmatdoost, A., Sheikh, M., Boffetta, P., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001229 · Cited by 57 · see citing works

Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice

Koop, A. C., Thiele, N. D., Steins, D., Michaëlsson, E., Wehmeyer, M., Scheja, L., Steglich, B., Huber, S., Schulze zur Wiesch, J., Lohse, A. W., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1566 · Cited by 48 · see citing works

Increased Serum Dihomo-γ-linolenic Acid Levels Are Associated with Obesity, Body Fat Accumulation, and Insulin Resistance in Japanese Patients with Type 2 Diabetes

Tsurutani, Y., Inoue, K., Sugisawa, C., Saito, J., Omura, M., & Nishikawa, T. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0816-18 · Cited by 47 · see citing works

Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis

Zhang, J.-Z., Cai, J., Yu, Y., She, Z., & Li, H. (2019) · Gene Expression · doi:10.3727/105221619x15553433838609 · Cited by 42 · see citing works

Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis

Gabbia, D., Roverso, M., Guido, M., Sacchi, D., Scaffidi, M., Carrara, M., Orso, G., Russo, F. P., Floreani, A., Bogialli, S., et al. (2019) · Nutrients · doi:10.3390/nu11071602 · Cited by 42 · see citing works

Distribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4,032 individuals. Reference values according to age and sex. D.E.S.I.R. Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance.

Gallois, Y., Vol, S., Cacès, E., & Balkau, B. (1996) · PubMed · Cited by 38 · see citing works

Changing NAFLD Epidemiology in China

Lee, H. W., & Wong, V. W. (2019) · Hepatology · doi:10.1002/hep.30848 · Cited by 36 · see citing works

NAFLD-related mortality: simple hepatic steatosis is not as ‘benign’ as thought

Tilg, H., & Targher, G. (2020) · Gut · doi:10.1136/gutjnl-2020-323188 · Cited by 33 · see citing works

Metabolomic Biomarkers in the Diagnosis of Non-Alcoholic Fatty Liver Disease

Chashmniam, S., Ghafourpour, M., Farimani, A. R., Gholami, A., & Gh, B. F. N. M. (2019) · Hepatitis Monthly · doi:10.5812/hepatmon.92244 · Cited by 32 · see citing works

Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Wong, T., Wong, R. J., & Gish, R. G. (2019) · Europe PMC (PubMed Central) · Cited by 29 · see citing works

Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity

Tas, E., Bai, S., Ou, X., Mercer, K. E., Lin, H., Mansfield, K., Buchmann, R. F., Diaz, E. C., Oden, J. D., Børsheim, E., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00654 · Cited by 20 · see citing works

Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis

Takada, S., Matsubara, T., Fujii, H., Sato-Matsubara, M., Daikoku, A., Odagiri, N., Amano‐Teranishi, Y., Kawada, N., & Ikeda, K. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00509-x · Cited by 14 · see citing works

Abdominal Subcutaneous Fat: A Favorable or Nonfunctional Fat Depot for Glucose Metabolism in Chinese Adults?

Hou, X., Chen, P., Hu, G., Wei, L., Jiao, L., Wang, H., Liang, Y., Bao, Y., & Jia, W. (2018) · Obesity · doi:10.1002/oby.22183 · Cited by 12 · see citing works

Erratum: Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study

Hodson, L., Bhatia, L. S., Scorletti, E., Smith, D. E., Jackson, N. C., Shojaee‐Moradie, F., Umpleby, M., Calder, P. C., & Byrne, C. D. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.145 · Cited by 9 · see citing works

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

Targher, G., Byrne, C. D., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330595 · Cited by 997 · see citing works

Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations

Ni, Y., Qian, L., Siliceo, S. L., Long, X., Nychas, E., Liu, Y., Ismaiah, M. J., Leung, H., Zhang, L., Gao, Q., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.08.002 · Cited by 231 · see citing works

Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications

Fang, J., Yu, C.-H., Li, X.-J., Yao, J., Fang, Z., Yoon, S., & Wenying, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.997018 · Cited by 212 · see citing works

The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease

Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207 · see citing works

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works

Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma

Lau, H. C.-H., Zhang, X., & Yu, J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01089-1 · Cited by 112 · see citing works

Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment

Ghosh, S., Zhao, X., Alim, M., Brudno, M., & Bhat, M. (2024) · Gut · doi:10.1136/gutjnl-2023-331740 · Cited by 101 · see citing works

Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease

Long, Q., Luo, F., Li, B., Li, Z., Guo, Z., Chen, Z., Wu, W., & Hu, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000310 · Cited by 94 · see citing works

Astragalus polysaccharides attenuate chemotherapy-induced immune injury by modulating gut microbiota and polyunsaturated fatty acid metabolism

Wang, H., Zhu, W., Hong, Y., Wei, W., Zheng, N., He, X., Bao, Y., Gao, X., Huang, W., Sheng, L., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155492 · Cited by 89 · see citing works

Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options

Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100018 · Cited by 94 · see citing works

NASH drug treatment development: challenges and lessons

Tilg, H., Byrne, C. D., & Targher, G. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00159-0 · Cited by 81 · see citing works

A comprehensive overview of microbiome data in the light of machine learning applications: categorization, accessibility, and future directions

Kumar, B., Lorusso, E., Fosso, B., & Pesole, G. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1343572 · Cited by 87 · see citing works

Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review

Li, H., Liang, J., Han, M., & Gao, Z. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.004 · Cited by 79 · see citing works

Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy

Zhu, L.-R., Li, S., Zheng, W.-Q., Ni, W., Cai, M., & Liu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1086078 · Cited by 76 · see citing works

Composition of gut microbiota and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

Su, X. B., Chen, S., Liu, J., Feng, Y., Han, E., Hao, X., Liao, M., Cai, J., Zhang, S., Niu, J., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13646 · Cited by 74 · see citing works

Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism

Zhang, X., Chen, L., Yang, J., Zhao, S.-S., Jin, S., Ao, N., Yang, J., Liu, H., & Du, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1117644 · Cited by 66 · see citing works

Nonalcoholic Fatty Liver Disease and Omega-3 Fatty Acids: Mechanisms and Clinical Use

Spooner, M. H., & Jump, D. Β. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061021-030223 · Cited by 60 · see citing works

Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer

Li, C., Cai, C., Wang, C., Chen, X., Zhang, B., & Huang, Z. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0857 · Cited by 56 · see citing works

Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)

Guo, Q., Li, Y., Dai, X., Wang, B., Zhang, J., & Cao, H. (2023) · Nutrients · doi:10.3390/nu15173722 · Cited by 50 · see citing works

Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression

Yang, C., Wu, J., Yang, L., Hu, Q., Li, L., Yang, Y., Jing Hua, H. U., Pan, D., & Zhao, Q. (2024) · Scientific Reports · doi:10.1038/s41598-024-72909-8 · Cited by 47 · see citing works

Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease

Ying, X., Rongjiong, Z., Kahaer, M., Chunhui, J., & Wulasihan, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1088187 · Cited by 47 · see citing works

Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults

Zeng, F., Su, X., Liang, X., Liao, M., Zhong, H., Xu, J., Gou, W., Zhang, X., Shen, L., Zheng, J., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03317-y · Cited by 43 · see citing works

Arbuscular mycorrhizal fungi build a bridge for soybeans to recruit Pseudomonas putida

Qiu, W., Kang, J., Ye, Z., Yang, S., Tu, X., Xie, P., Ge, J., Ping, W., & Yuan, J. J. (2025) · New Phytologist · doi:10.1111/nph.70064 · Cited by 43 · see citing works

Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease

Wu, H., Chen, J., Guo, S., Deng, J., Zhou, Z., Zhang, X., Qi, T., Yu, F., & Yang, Q. L. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2500099 · Cited by 41 · see citing works

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease

Scarpellini, E., Scarcella, M., Tack, J. F., Scarlata, G. G. M., Zanetti, M., & Abenavoli, L. (2024) · Antioxidants · doi:10.3390/antiox13111386 · Cited by 39 · see citing works

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD

Liu, J., Wu, A., Cai, J., She, Z., & Li, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968799 · Cited by 37 · see citing works

Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome

Friedman, S. L. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0240 · Cited by 37 · see citing works

Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD

Long, X., Wang, H., Lu, Y., Gao, X., Xiao, Y., Zhang, M., Guo, J., Yang, H. J., Zhang, R., Li, Q., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.017 · Cited by 37 · see citing works

Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease

Nychas, E., Marfil-Sánchez, A., Chen, X., Mirhakkak, M. H., Li, H., Jia, W., Xu, A., Nielsen, H. B., Nieuwdorp, M., Loomba, R. S., et al. (2025) · Microbiome · doi:10.1186/s40168-024-01990-y · Cited by 33 · see citing works

Credible inferences in microbiome research: ensuring rigour, reproducibility and relevance in the era of AI

Caminero, A., Tropini, C., Valles‐Colomer, M., Shung, D. L., Gibbons, S. M., Surette, M. G., Sokol, H., Tomeo, N. J., Alenghat, T., Awoniyi, M., et al. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01100-9 · Cited by 35 · see citing works

Saccharomyces cerevisiae fermentation product improves robustness of equine gut microbiome upon stress

Ganda, E., Chakrabarti, A., Sardi, M. I., Tench, M., Kozlowicz, B. K., Norton, S. A., Warren, L. K., & Khafipour, E. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1134092 · Cited by 30 · see citing works

Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis

Zhang, J., Shen, Y., Chen, X.-Y., Jiang, M.-L., Yuan, F.-H., Xie, S.-L., Zhang, J., & Xu, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1115890 · Cited by 30 · see citing works

Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives

Mao, Q., Lin, B., Zhang, W., Zhang, Y., Zhang, Y., Cao, Q., & Xu, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1371574 · Cited by 29 · see citing works

The role of the gut microbiome in the development of hepatobiliary cancers

Daniel, N., Genua, F., Jenab, M., Mayén, A., Chatziioannou, A. C., Keski‐Rahkonen, P., & Hughes, D. J. (2023) · Hepatology · doi:10.1097/hep.0000000000000406 · Cited by 28 · see citing works

Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management

Rinella, M. E., & Sookoian, S. C. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01187-8 · Cited by 29 · see citing works

Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation

Xiang, Z., Wu, J., Li, J., Zheng, S., Wei, X., & Xu, X. (2023) · Engineering · doi:10.1016/j.eng.2022.12.012 · Cited by 27 · see citing works

Physical exercise plays a role in rebalancing the bile acids of enterohepatic axis in non‐alcoholic fatty liver disease

Zhang, M., Xiao, B., Chen, X., Ou, B., & Wang, S. (2023) · Acta Physiologica · doi:10.1111/apha.14065 · Cited by 26 · see citing works

Liver sinusoidal endothelial cells: Friend or foe in metabolic dysfunction- associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis

Dai, Q., Ain, Q., Seth, N., Rooney, M., & Zipprich, A. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.01.189 · Cited by 24 · see citing works

Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes

Zhang, L., Marfil-Sánchez, A., Kuo, T.-H., Seelbinder, B., van Dam, L., Depetris-Chauvin, A., Jahn, L. J., Sommer, M. O. A., Zimmermann, M., Ni, Y., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02197-z · Cited by 23 · see citing works

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism

Tang, Y. J., Chen, B., Huang, X., He, X., Yi, J., Zhao, H. L., Tian, F., Liu, Y., & Liu, B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1062323 · Cited by 22 · see citing works

Maternal and infant microbiome: next-generation indicators and targets for intergenerational health and nutrition care

Gao, S., & Wang, J. (2023) · Protein & Cell · doi:10.1093/procel/pwad029 · Cited by 22 · see citing works

Gut Feelings: How Microbes, Diet, and Host Immunity Shape Disease

Theis, B. F., Park, J. S., Kim, J. S., Zeydabadinejad, S., Vijay–Kumar, M., Yeoh, B. S., & Saha, P. (2025) · Biomedicines · doi:10.3390/biomedicines13061357 · Cited by 24 · see citing works

Gut microbiota in liver diseases: initiation, development and therapy

Yu, J., Wu, J., Chen, X., Zang, S.-G., Li, X., Wu, L., & Xuan, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1615839 · Cited by 20 · see citing works

Dissection of gut microbiota and metabolites reveals the hypolipidemic effect of green mulberry leaf tea / black mulberry leaf tea in mice

Zhong, S. S., Yang, Y., Huo, J., Sun, Y., Ren, N., Lu, Q., Li, D., Zhan, P., Wu, W., Chen, H., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105906 · Cited by 19 · see citing works

Identification of microbial markers associated with lung cancer based on multi‐cohort 16 s rRNA analyses: A systematic review and meta‐analysis

Han, W., Wang, N., Han, M., Liu, X., Sun, T., & Xu, J. (2023) · Cancer Medicine · doi:10.1002/cam4.6503 · Cited by 18 · see citing works

The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis

Sharma, S., Tiwari, N., & Tanwar, S. S. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04069-z · Cited by 18 · see citing works

Roadmap for the integration of gastro‐intestinal (GI) tract microbiomes (human and domestic animal) in risk assessments under EFSA's remit

Moreno, F. J., Pazos, F., Garrido‐Romero, M., Payen, C., Borrego‐Yaniz, G., Chagoyen, M., Corzo, N., Denis, M., Fablet, C., Fernández, M., et al. (2024) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2024.en-8597 · Cited by 17 · see citing works

High methionine intake alters gut microbiota and lipid profile and leads to liver steatosis in mice

Zhou, L., Yan, Z., Yang, S., Lu, G., Nie, Y., Ren, Y., Xue, Y., Shi, J., Xu, Z., & Geng, Y. (2024) · Food & Function · doi:10.1039/d4fo01613k · Cited by 18 · see citing works

Lactobacillus sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice

Olotu, T., & Ferrell, J. M. (2024) · Microorganisms · doi:10.3390/microorganisms12122488 · Cited by 16 · see citing works

Alcohol drinking alters oral microbiota to modulate the progression of alcohol-related liver disease

Pan, C., Liu, C., Jia, W., Zhao, D., Chen, X., Zhu, X., Yang, M., & Wang, L. (2023) · iScience · doi:10.1016/j.isci.2023.107977 · Cited by 16 · see citing works

Harnessing human microbiomes for disease prediction.

Liu, Y., Fachrul, M., Inouye, M., & Méric, G. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2023.12.004 · Cited by 14 · see citing works

Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics

Pandey, H., Goel, P., Srinivasan, V. M., Tang, D. W. T., Wong, S. H., & Lal, D. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i6.106849 · Cited by 17 · see citing works

Hepatobiliary and pancreatic: Multi‐donor fecal microbiota transplantation attenuated high‐fat diet‐induced hepatic steatosis in mice by remodeling the gut microbiota

Shou, D., Luo, Q., Tang, W., Cao, C.-Y., Huang, H., Chen, H., & Zhou, Y. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16359 · Cited by 15 · see citing works

Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Abdollahiyan, S., Nabavi-Rad, A., Raftar, S. K. A., Monnoye, M., Salarieh, N., Farahanie, A., Aghdaei, H. A., Zali, M. R., Hatami, B., Gérard, P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47905-z · Cited by 15 · see citing works

Development and evaluation of statistical and artificial intelligence approaches with microbial shotgun metagenomics data as an untargeted screening tool for use in food production

Beck, K. L., Haiminen, N., Agarwal, A., Carrieri, A. P., Madgwick, M., Kelly, J., Pylro, V. S., Kawas, B., Wiedmann, M., & Ganda, E. (2024) · mSystems · doi:10.1128/msystems.00840-24 · Cited by 15 · see citing works

Roles of gut microbes in metabolic-associated fatty liver disease

Chen, C., & Ho, H. (2023) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_86_23 · Cited by 14 · see citing works

A universal plasma metabolites-derived signature predicts cardiovascular disease risk in MAFLD

Li, Z., Gong, R., Chu, H., Zeng, J., Chen, C., Xu, S., Hu, L., Gao, W., Li, Z., Yuan, H., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117526 · Cited by 14 · see citing works

Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

Popov, J., Despot, T., Rodriguez, D. A., Khan, I. I., Mech, E., Khan, M. A., Bojadzija, M., & Pai, N. (2024) · Nutrients · doi:10.3390/nu16111668 · Cited by 15 · see citing works

A critical review of microbiome-derived metabolic functions and translational research in liver diseases

Ganesan, R., Thirumurugan, D., Vinayagam, S., Kim, D. J., Suk, K. T., Iyer, M., Yadav, M., HariKrishnaReddy, D., Parkash, J., Wander, A., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1488874 · Cited by 14 · see citing works

Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota

Yang, W., Jin, Q., Xiao, D., Li, X., & Huang, D. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1597995 · Cited by 13 · see citing works

Uncovering the Gut–Liver Axis Biomarkers for Predicting Metabolic Burden in Mice

Yang, G., Liu, R., Rezaei, S., Liu, X., & Wan, Y. Y. (2023) · Nutrients · doi:10.3390/nu15153406 · Cited by 13 · see citing works

Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data

Zou, Y., Yue, M., Jia, L., Wang, Y., Chen, H., Zhang, A., Xia, X., Liu, W., Yu, R., Yang, S., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11628-1 · Cited by 13 · see citing works

Gut Microbiome—How Does Two-Month Consumption of Fiber-Enriched Rolls Change Microbiome in Patients Suffering from MASLD?

Kaźmierczak-Siedlecka, K., Maciejewska, D., Sykulski, M., Gruszczyńska, A., Herman-Iżycka, J., Wyleżoł, M., Petriczko, K. K., Palma, J., Jakubczyk, K., Janda, K., et al. (2024) · Nutrients · doi:10.3390/nu16081173 · Cited by 13 · see citing works

Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives

Chen, Y., Bian, S., & Le, J. (2025) · Genes · doi:10.3390/genes16040399 · Cited by 11 · see citing works

Metabolic heterogeneity caused by HLA-DRB1*04:05 and protective effect of inosine on autoimmune hepatitis

Yang, F., Zhou, L., Shen, Y., Zhao, S., Zheng, Y., Men, R., Fan, X., & Yang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982186 · Cited by 12 · see citing works

Alcohol‐Related Liver Disease and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Molecular Pathogenesis and Therapeutic Interventions

Tan, Y., Hu, Y., Yang, Y., & Chu, H. (2025) · MedComm · doi:10.1002/mco2.70532 · Cited by 10 · see citing works

Microbial collagenase activity is linked to oral–gut translocation in advanced chronic liver disease

Jin, S., Cenier, A., Wetzel, D., Arefaine, B., Moreno‐Gonzalez, M., Stamouli, M., Mohamad, M., Lupatsii, M., Ríos, E. G., Lee, S., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02223-0 · Cited by 10 · see citing works

Common Denominator of MASLD and Some Non-Communicable Diseases

Ferenc, K., Jarmakiewicz-Czaja, S., Sokal-Dembowska, A., Stasik, K., & Filip, R. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070399 · Cited by 9 · see citing works

Full-length 16S rRNA Sequencing Reveals Gut Microbiome Signatures Predictive of MASLD in children with obesity

Lin, Y., Wu, C.-C., Li, Y.-E., Chen, C., Lin, C.-R., & Ni, Y. (2025) · BMC Microbiology · doi:10.1186/s12866-025-03849-0 · Cited by 10 · see citing works

Multimodal Learning-based Prediction for Nonalcoholic Fatty Liver Disease

Chen, Y., Chen, X., Han, Y., Li, H., Zhao, D., Li, J., Wang, X., & Zhou, Y. (2025) · Machine Intelligence Research · doi:10.1007/s11633-024-1506-4 · Cited by 10 · see citing works

Harnessing lactobacillus : a probiotic revolution in combating metabolic dysfunction-associated steatotic liver disease

Gu, M., Hong, Q., Cui, J., Li, W., Zhang, J., Sun, Y., Jiang, J., & Hu, Y. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2504162 · Cited by 10 · see citing works

Targeting the gut-liver axis with dietary polyphenols to ameliorate metabolic dysfunction-associated steatotic liver disease: advances in molecular mechanisms

Hu, Z., He, Z., Wang, Y., Chu, Z., Zhou, Y., Li, W., Lu, J., Lin, Q., & Luo, F. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2556470 · Cited by 11 · see citing works

Circulating glycerate predicts resilience to fructose-induced hepatic steatosis

Ramirez, C. B., Ahn, I. S., Rubtsova, V. I., Cely, I., Le, J., Kim, J., Jung, S., Kelly, M. E., Kim, Y., Bae, H., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.03.017 · Cited by 9 · see citing works

Regulation of gut microbiota by ginger, its derived polysaccharides, essential oils, gingerols, and shogaols and related health outcomes

Shen, L., & Ji, H. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.146006 · Cited by 9 · see citing works

Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice

Spooner, M. H., García‐Jaramillo, M., Apperson, K. D., Löhr, C. V., & Jump, D. Β. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292432 · Cited by 9 · see citing works

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives

Cazac, G.-D., Lăcătușu, C.-M., Ștefănescu, G., Mihai, C., Grigorescu, E.-D., Onofriescu, A., & Mihai, B. M. (2023) · Metabolites · doi:10.3390/metabo13050581 · Cited by 9 · see citing works

Evolutionary genomics of white spot syndrome virus

Kawato, S., Omine, R., Teruya, S., Kubo, H., Yasumoto, S., Kondo, M., Takahashi, Y., Nozaki, R., Kondo, H., & Hırono, I. (2023) · Fisheries Science · doi:10.1007/s12562-023-01715-4 · Cited by 8 · see citing works

Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease

Zhang, Y., Wang, T., Han, J., Song, J., Yang, C., Liang, L., Li, H., & Wang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610498 · Cited by 7 · see citing works

Metabolic and hepatic biomarkers associated with MASLD in the Chinese population

Chen, H., Chen, Z., Bai, X., Li, Z., Huang, S., Li, J., Li, J., Wang, Y., Han, L., Xia, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-17219-3 · Cited by 7 · see citing works

Anaerobutyricum soehngenii Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice

Mak, A. L., Augustijn, Q. J. J., Heymann, C. J. F., Havik, S. R., Verdoes, X., Ríos-Morales, M., Bosmans, L. A., Verheij, J., Meijnikman, A. S., de Jonge, P. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063481 · Cited by 7 · see citing works

Identification of commensal gut bacterial strains with lipogenic effects contributing to NAFLD in children

Wei, J., Luo, J., Yang, F., Dai, W., Pan, X., & Luo, M. (2024) · iScience · doi:10.1016/j.isci.2024.108861 · Cited by 7 · see citing works

Integrated microbiome and metabolome analysis reveals a novel interplay between gut microbiota and metabolites in differentiated thyroid carcinoma

Xue, J., Liu, Q., Xu, D., Pang, H., & Shi, Y. (2025) · BMC Microbiology · doi:10.1186/s12866-025-03877-w · Cited by 6 · see citing works

The gut as a central hub for multi-organ crosstalk in aging

Zhang, X., Li, R., Gao, Y., Zhang, W., Ni, T., & Liu, Y. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06129-w · Cited by 6 · see citing works

Alterations of the duodenal mucosal microbiome in patients with metabolic dysfunction-associated steatotic liver disease

Ren, M., Pan, H., Zhou, X., Yu, M., & Ji, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-59605-3 · Cited by 6 · see citing works

In Vitro Influence of Specific Bacteroidales Strains on Gut and Liver Health Related to Metabolic Dysfunction-Associated Fatty Liver Disease

García-Morena, D., Fernández-Cantos, M. V., Lopez-Escalera, S., Lok, J., Iannone, V., Cancellieri, P., Maathuis, W., Panagiotou, G., Aranzamendi, C., Aidy, S. E., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10219-1 · Cited by 6 · see citing works

D-Psicose mitigates NAFLD mice induced by a high-fat diet by reducing lipid accumulation, inflammation, and oxidative stress

Tan, J., Sun, W., Dong, X., He, J., Ali, A. M. M., Chen, M., Zhang, L., Wu, L., & Shao, K. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1574151 · Cited by 5 · see citing works

Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome

Zheng, N., Wang, D., Xing, G., Gao, Y., Li, S., Liu, J., Kang, J., Sha, S., Cheng, L., Fan, S., et al. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04348-y · Cited by 5 · see citing works

The Role of Traditional Chinese Medicine in the Management of Nonalcoholic Fatty Liver Disease: Targeting Gut Microbiome

Zhang, Y., Li, H., Jiang, N., & Ru, Q. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500788 · Cited by 5 · see citing works

Mendelian randomization suggests a causal relationship between gut microbiota and nonalcoholic fatty liver disease in humans

Dai, X., Jiang, K., Ma, X., Hu, H., Mo, X., Huang, K., Jiang, Q., Chen, Y., & Liu, C. (2024) · Medicine · doi:10.1097/md.0000000000037478 · Cited by 5 · see citing works

Gut Microbiome and Metabolome Dynamics as Predictors of Clinical Outcomes in Hematopoietic Stem Cell Transplantation

Kim, J., Kim, Y. J., Lee, Y. J., Lee, H., Sim, I., Koh, S., Suh, D. H., Jung, E. S., & Jo, J. (2025) · MedComm · doi:10.1002/mco2.70334 · Cited by 4 · see citing works

Silymarin as a Redox-Signalling and Proteostasis Modulator

de la Lastra, J. M. P., Andrés, C. M. C., Munguira, E. B., Juan, C. A., & Lebeña, E. P. (2026) · Nutraceuticals · doi:10.3390/nutraceuticals6020025 · Cited by 5 · see citing works

Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease

IGUDESMAN, D. A., Yu, G., Dauriat, C. J. G., Roman, T., Kashi, M. R., Blakley, E. A., Chassaing, B., & Corbin, K. D. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00381.2024 · Cited by 4 · see citing works

Comparison of the effects and mechanisms of astaxanthin, astaxanthin esters and astacene on high-fat diet-induced NAFLD

Gao, C., Chen, F., Gong, N., Hu, S., Zhu, M., Zhou, Q., & Gao, X. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106985 · Cited by 4 · see citing works

Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options

Ren, R., Liang, X., & Wei, X. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00486-5 · Cited by 4 · see citing works

Risk of Serious Bacterial and Non‐Bacterial Infections in People With MASLD

Targher, G., Tilg, H., & Valenti, L. V. C. (2025) · Liver International · doi:10.1111/liv.70059 · Cited by 4 · see citing works

Characterization of the gut virome in patients with nonalcoholic fatty liver disease

Wang, L., Wang, L., Liu, M., Yuan, Q., Cheng, L., Chen, H., Mao, S., Li, S., Yan, Q., Xing, G., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07443-w · Cited by 3 · see citing works

Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of Gastroenterology

Alexander, J. B., Mullish, B. H., Thomas, L., Weersma, R. K., Sokol, H., Roberts, L. A., Edwards, L. A., Emmanuel, A. V., Gerasimidis, K., Hall, L. J., et al. (2026) · Gut · doi:10.1136/gutjnl-2026-338252 · Cited by 3 · see citing works

Gut microbes of the cecum versus the colon drive more severe lethality and multi-organ damage

Xu, K., Tan, J., Lin, D., Jiang, H., Chu, Y., Zhou, L., Zhang, J., & Lu, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114029 · Cited by 3 · see citing works

Systematic Review and Meta‐Analysis of the Effects of Intestinal Microbiota on Liver Disease Using Mendelian Randomization

Xu, C., Li, X., Wang, H., Yue, Z., Shen, L., He, J., Liu, Z., & Zhao, W. (2025) · JGH Open · doi:10.1002/jgh3.70165 · Cited by 2 · see citing works

Biostimulant-induced phosphorus activation in soils: mechanisms and efficacy of polyglutamic and humic acids

Yang, M., Su, J., Lv, H., Jia, H., Yun, W., Liu, J., & Zhao, G. (2025) · Applied Soil Ecology · doi:10.1016/j.apsoil.2025.106713 · Cited by 2 · see citing works

A nested case-control study on the relationship between gut microbiota and non-alcoholic fatty liver disease

Yang, X., Chen, J., Song, J., Liu, H., Wang, L., Li, T., Yan, H., Gao, X., & Ding, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1917815

Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults

Zeng, F., Su, X., Liang, X., Liao, M., Zhong, H., Xu, J., Gou, W., Zhang, X., Shen, L., Zheng, J., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03317-y · Cited by 43 · see citing works

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123 · see citing works

A Gut Microbiome Signature for Cirrhosis Due to Nonalcoholic Fatty Liver Disease

Caussy, C., Tripathi, A., Humphrey, G., Bassirian, S., Singh, S., Faulkner, C., Bettencourt, R., Rizo, E., Richards, L., Xu, Z. Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09455-9 · Cited by 338 · see citing works

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients

Ge, H., Wei, W., Tang, L., Tian, Y., Zhu, Y. K., Luo, Y., & Liu, S. (2022) · Medicine · doi:10.1097/md.0000000000029347 · Cited by 13 · see citing works